Clinical and Hematological Profile of β-Thalassemia Minor
Mubashir Razzaq Khan, Aamal Zeb, Tariq Zulfiqar
340
ABSTRACT
Background: β-thalassemia minor is the
most common inherited hemoglobinopathy worldwide. The defect lies in the beta
globin chain synthesis as a result of mutations in beta globin chain genes.
Clinical presentation is variable, ranging from normal hemoglobin to severe
anemia. Haematologically, classically, there is microcytosis, hypochromia,
raised red blood cell count, and elevated HbA2 on hemoglobin studies. But these
findings considerably overlap with some added factor, such as, isolated or
combine nutritional deficiencies.
Aims: To evaluate the clinical and
hematological profile of β-thalassemia minor cases, and, to make a protocol to
investigate the patients having microcytic hypochromic anemia for carrier state
of hemoglobinopathies especially thalassemia.
Study Design: Descriptive
study.
Place and duration of study: Hematology
OPD, Faisalabad Institute of Cardiology, Faisalabad from 1st January
2018 to 31st December 2020.
Methodology: 3520
patients were referred to our clinic for workup of microcytic hypochromic
anemia. CBC and HbA2 testing was done on all cases. Out of those,
111 fell into our criteria of the diagnosis of β-thalassemia minor.
Results: Ninety one (81.9%) of the patients presented with
pallor. Tachycardia and shortness of breath was a complaint in 46 (41.4%) and
30 (27%) respectively. The
hemoglobin mean of 9.1 (range 2.7-14.5 g/dL). Red cell distribution width
RDW-CV of RBCs was ≤18% in 48.6% of the patients. Mean MCV was 73.3fL (range
54-156), mean RBCs count was 4.75 (range 0.8-7.6). Hemoglobin on HPLC of Biorad
Variant II Beta Thalassemia Short Program revealed a raised HbA2 in
100% of the patients of β-thalassemia minor. Iron deficiency was found to be in
35% of the total diagnosed β-thalassemia minor patients with mean concentration
of Ferritin 13.3 ng/mL (range 0.8-80).
Conclusions: All patients with microcytic, hypochromic anemia and
raised RBC count should be screened on HPLC for demonstration of HbA2 to
exclude β-thalassemia minor. Microcytosis (MCV <76fL), Borderline raised RBC
count (RBCs >5x1012/L), Borderline high or low RDW (<18), and
a raised HbA2 level are highly consistent with the diagnosis of
β-thalassemia minor.
Keywords: β-thalassemia minor, Hemoglobin
A2 (HbA2), Microcytic hypochromic Anemia, HPLC, Thalassemia minor